Update on immunotherapy in melanoma Journal Article
| Authors: | Green, J.; Ariyan, C. |
| Article Title: | Update on immunotherapy in melanoma |
| Abstract: | Immunotherapy is now recognized as a viable option for patients with metastatic melanoma. The field of immunotherapy now offers treatments with the potential for a long-term cure. As the field moves forward, studies will focus on improving the response rates with new immunotherapy agents or novel treatment combinations. © 2015 Elsevier Inc. |
| Keywords: | cancer survival; cancer surgery; hepatitis; placebo; cancer combination chemotherapy; diarrhea; drug dose reduction; drug efficacy; drug safety; monotherapy; nonhuman; unspecified side effect; drug megadose; antineoplastic agent; bcg vaccine; dacarbazine; interleukin 2; ipilimumab; cancer immunotherapy; melanoma; infection; liver toxicity; imiquimod; nausea; vomiting; fever; rash; hypotension; immunotherapy; cancer immunization; drug response; limb swelling; adoptive transfer; colitis; innate immunity; dermatitis; adaptive immunity; endocrine disease; drug protein binding; tachycardia; metastatic melanoma; antitumor immunity; neuritis; melanocyte protein pmel 17; nivolumab; onamelatucel l; human; article; costimulatory blockade |
| Journal Title: | Surgical Oncology Clinics of North America |
| Volume: | 24 |
| Issue: | 2 |
| ISSN: | 1055-3207 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-04-01 |
| Start Page: | 337 |
| End Page: | 346 |
| Language: | English |
| DOI: | 10.1016/j.soc.2014.12.010 |
| PROVIDER: | scopus |
| PUBMED: | 25769716 |
| DOI/URL: | |
| Notes: | Export Date: 4 May 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work